MVA Multi-Filo Ebola Vaccine
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
Ebola DiseaseImmunisationMarburg Disease
Phase 1
A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
CompletedNCT02891980
Start: 2017-03-24End: 2019-03-21Updated: 2025-07-29
A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)
CompletedNCT03583606
Start: 2018-11-12End: 2020-01-14Updated: 2025-07-29